Mifepristone

Korlym

Progestin Antagonist

NADAC/unit N/A

No Shortage Tier 1: 19.1% PA Req: 102.1% 3 Manufacturers 3 ANDAs

KORLYM (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes m....

Covered Lives

Generic Manufacturers

CORCEPT THERAPEUTICS INCDANCO LABORATORIES LLCEVITA SOLUTIONS LLCGENBIOPRO INCTEVA PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Mifepristone drfinder.aiFind doctors who prescribe Mifepristone rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Mifepristone

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.